CVS HEALTH Corp Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0000064803
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 5 positions · Total reported value $230.20M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 53.8% · 18 new · 0 cut · 3 exited
Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -3.7% · vs SPY -5.8% · Prev Value $225.17M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +1.7% · vs SPY -0.4% · Latest Value $429.36M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2024 13F filing, CVS HEALTH Corp disclosed 5 equity positions with a combined reported value of $230.20M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q3 2024 were SPY ($165.18M), VYM ($32.31M), HDV ($32.12M). By sector, the heaviest allocations are Financials 0.1%, Information Technology 0.1%.
Versus the prior quarter, CVS HEALTH Corp opened 18 new positions, trimmed 0 and fully exited 3, a turnover rate of 53.8% of positions. The portfolio's overlap with the prior quarter was 83% of names.
Of the 3 positions fully exited versus the prior quarter, the largest were LMDWF ($72.79K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
No new positions this quarter.
Fully Exited (vs previous quarter)
- LMDWF LUMIRADX LTD · prev qtr: $72.79K
Insider Transactions (Form 4)
Latest CVS HEALTH Corp buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
CVS HEALTH Corp files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 21 positions worth $225.17M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 21 positions · $225.17M reported value (Q2 2026)
- Top 10 holdings = 83.7% of reported value
- Largest position: IGSB (ISHARES TR) at 20.7%
- Average position size: $10.72M
Sector Tilt
- Financials 0.1%
- (classified holdings cover 0% of value)
Quarterly Activity
- Q2 2026: 4 new, 7 added, 1 reduced, 16 exited
- 9 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
287.89K | $165.18M | 71.75% | Hold | |
| 2 |
|
252.03K | $32.31M | 14.04% | Hold | |
| 3 |
|
273.11K | $32.12M | 13.95% | Hold | |
| 4 |
|
2.68K | $324.91K | 0.14% | Hold | |
| 5 |
|
32.27K | $262.70K | 0.11% | Hold |
FAQ
What did CVS HEALTH Corp buy in 2024-Q3?
In its 2024-Q3 13F filing, CVS HEALTH Corp reported 5 equity positions worth $230.20M in aggregate; its largest disclosed positions were SPY ($165.18M), VYM ($32.31M), HDV ($32.12M).
How large is CVS HEALTH Corp's portfolio?
CVS HEALTH Corp reported $230.20M of long equity holdings across 5 positions as of 2024-Q3. Top-10 holdings account for 100.0% of reported value.
What is CVS HEALTH Corp's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.